Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors.
Feldman DR; Turkula S; Ginsberg MS; Ishill N; Patil S; Carousso M; Bosl GJ; Motzer RJ; Investigational New Drugs, 2010, vol. 28, issue 4, p 523, ISSN 15730646. ISBN 15730646.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef